Literature DB >> 3275891

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin.

D J Norman, D R Illingworth, J Munson, J Hosenpud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275891     DOI: 10.1056/NEJM198801073180110

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  40 in total

Review 1.  Calcineurin inhibitors and post-transplant hyperlipidaemias.

Authors:  R Moore; D Hernandez; H Valantine
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.

Authors:  M H Davidson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

4.  Rhabdomyolysis associated with lovastatin and erythromycin use.

Authors:  D H Spach; J E Bauwens; C D Clark; W G Burke
Journal:  West J Med       Date:  1991-02

Review 5.  Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.

Authors:  C Köppel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 6.  Antihyperlipidaemic agents. Drug interactions of clinical significance.

Authors:  J A Farmer; A M Gotto
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

7.  Tissue-selective inhibition of sterol synthesis in mice by pravastatin sodium after a single or repeated oral administrations.

Authors:  T Koga; T Kikuchi; A Miyazaki; H Koike
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

Review 8.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 9.  Drug interactions of lipid-altering drugs.

Authors:  H E Bays; C A Dujovne
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

10.  [Severe rhabdomyolysis in a patient receiving lovastatin, danazol, and doxycycline].

Authors:  M Dallaire; M Chamberland
Journal:  CMAJ       Date:  1994-06-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.